Switching from tenofovir disoproxil fumarate to tenofovir alafenamide: perhaps not as simple as we thought

Lancet Gastroenterol Hepatol. 2020 May;5(5):420-421. doi: 10.1016/S2468-1253(19)30450-9. Epub 2020 Feb 20.
No abstract available

MeSH terms

  • Adenine / administration & dosage
  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Alanine
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects
  • Cholesterol, LDL / blood*
  • Drug Monitoring
  • Drug Substitution / adverse effects
  • Drug Substitution / methods
  • Glomerular Filtration Rate / drug effects*
  • Hepatitis B virus / drug effects
  • Hepatitis B virus / isolation & purification
  • Hepatitis B, Chronic* / diagnosis
  • Hepatitis B, Chronic* / drug therapy
  • Hepatitis B, Chronic* / metabolism
  • Humans
  • Lipid Metabolism / drug effects*
  • Risk Assessment
  • Tenofovir* / administration & dosage
  • Tenofovir* / adverse effects

Substances

  • Antiviral Agents
  • Cholesterol, LDL
  • Tenofovir
  • tenofovir alafenamide
  • Adenine
  • Alanine